CC-10004
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for CC-10004, covering 2013-04-12 to 2020-04-24. Get the full timeline:
Most recent: Clinical Trial Update: Double-Blind, Randomized, Placebo-controlled Comparison of CC-10004 in Subjects With Moderate to Severe Plaque Type Psoriasis [Phase 2]